 | • レポートコード：GIR-105X14212 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子組換え型B型肝炎ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子組換え型B型肝炎ワクチンの種類別市場規模（10mcg/ml、10mcg/0.5ml）、用途別市場規模（新生児、小学生、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子組換え型B型肝炎ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、GlaxoSmithKline Plc、Pfizer Inc.、Sanofi Pasteur、CSL Limited、Emergent Biosolutions、Serum Institute of India、Johnson & Johnson、Hualan Biological Engineering、NCPC、China National Biotec Group、Dalian Hissen Bio-pharm、Beijing Tiantan Biological ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：10mcg/ml、10mcg/0.5ml ・用途別分析2016年-2026年：新生児、小学生、大人 ・遺伝子組換え型B型肝炎ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子組換え型B型肝炎ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子組換え型B型肝炎ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子組換え型B型肝炎ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子組換え型B型肝炎ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Recombinant Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Recombinant Hepatitis B Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Recombinant Hepatitis B Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Recombinant Hepatitis B Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10mcg/ml
10mcg/0.5ml
Market segment by Application can be divided into
Newborn
Primary School Students
Adult
The key market players for global Recombinant Hepatitis B Vaccine market are listed below:
Merck
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Hualan Biological Engineering
NCPC
China National Biotec Group
Dalian Hissen Bio-pharm
Beijing Tiantan Biological
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Recombinant Hepatitis B Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Hepatitis B Vaccine, with price, sales, revenue and global market share of Recombinant Hepatitis B Vaccine in 2018 and 2019.
Chapter 3, the Recombinant Hepatitis B Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Hepatitis B Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Recombinant Hepatitis B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Recombinant Hepatitis B Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Recombinant Hepatitis B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Hepatitis B Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 10mcg/ml
1.2.3 10mcg/0.5ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Hepatitis B Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Newborn
1.3.3 Primary School Students
1.3.4 Adult
1.4 Global Recombinant Hepatitis B Vaccine Market Size & Forecast
1.4.1 Global Recombinant Hepatitis B Vaccine Sales in Value (2016-2026))
1.4.2 Global Recombinant Hepatitis B Vaccine Sales in Volume (2016-2026)
1.4.3 Global Recombinant Hepatitis B Vaccine Price by Type (2016-2026) & (US$/Unit)
1.5 Global Recombinant Hepatitis B Vaccine Production Capacity Analysis
1.5.1 Global Recombinant Hepatitis B Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Hepatitis B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Hepatitis B Vaccine Market Drivers
1.6.2 Recombinant Hepatitis B Vaccine Market Restraints
1.6.3 Recombinant Hepatitis B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Recombinant Hepatitis B Vaccine Product and Services
2.1.4 Merck Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GlaxoSmithKline Plc
2.2.1 GlaxoSmithKline Plc Details
2.2.2 GlaxoSmithKline Plc Major Business
2.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product and Services
2.2.4 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer Inc.
2.3.1 Pfizer Inc. Details
2.3.2 Pfizer Inc. Major Business
2.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Product and Services
2.3.4 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business
2.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product and Services
2.4.4 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 CSL Limited
2.5.1 CSL Limited Details
2.5.2 CSL Limited Major Business
2.5.3 CSL Limited Recombinant Hepatitis B Vaccine Product and Services
2.5.4 CSL Limited Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Emergent Biosolutions
2.6.1 Emergent Biosolutions Details
2.6.2 Emergent Biosolutions Major Business
2.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product and Services
2.6.4 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Product and Services
2.7.4 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Product and Services
2.8.4 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Hualan Biological Engineering
2.9.1 Hualan Biological Engineering Details
2.9.2 Hualan Biological Engineering Major Business
2.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product and Services
2.9.4 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Recombinant Hepatitis B Vaccine Product and Services
2.10.4 NCPC Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 China National Biotec Group
2.11.1 China National Biotec Group Details
2.11.2 China National Biotec Group Major Business
2.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Product and Services
2.11.4 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Dalian Hissen Bio-pharm
2.12.1 Dalian Hissen Bio-pharm Details
2.12.2 Dalian Hissen Bio-pharm Major Business
2.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product and Services
2.12.4 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Beijing Tiantan Biological
2.13.1 Beijing Tiantan Biological Details
2.13.2 Beijing Tiantan Biological Major Business
2.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product and Services
2.13.4 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Recombinant Hepatitis B Vaccine Sales by Manufacturer
3.1 Global Recombinant Hepatitis B Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Hepatitis B Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Hepatitis B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Hepatitis B Vaccine Manufacturer Market Share
3.4.2 Top 6 Recombinant Hepatitis B Vaccine Manufacturer Market Share
3.5 Global Recombinant Hepatitis B Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Hepatitis B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Hepatitis B Vaccine Market Size by Region
4.1.1 Global Recombinant Hepatitis B Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Hepatitis B Vaccine Revenue by Region (2016-2026)
4.2 North America Recombinant Hepatitis B Vaccine Revenue (2016-2026)
4.3 Europe Recombinant Hepatitis B Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Hepatitis B Vaccine Revenue (2016-2026)
4.5 South America Recombinant Hepatitis B Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Hepatitis B Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Hepatitis B Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Hepatitis B Vaccine Revenue by Type (2016-2026)
5.3 Global Recombinant Hepatitis B Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Hepatitis B Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Hepatitis B Vaccine Revenue by Application (2016-2026)
6.3 Global Recombinant Hepatitis B Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Hepatitis B Vaccine Sales by Type (2016-2026)
7.2 North America Recombinant Hepatitis B Vaccine Sales by Application (2016-2026)
7.3 North America Recombinant Hepatitis B Vaccine Market Size by Country
7.3.1 North America Recombinant Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Hepatitis B Vaccine Sales by Type (2016-2026)
8.2 Europe Recombinant Hepatitis B Vaccine Sales by Application (2016-2026)
8.3 Europe Recombinant Hepatitis B Vaccine Market Size by Country
8.3.1 Europe Recombinant Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Hepatitis B Vaccine Market Size by Region
9.3.1 Asia-Pacific Recombinant Hepatitis B Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Hepatitis B Vaccine Sales by Type (2016-2026)
10.2 South America Recombinant Hepatitis B Vaccine Sales by Application (2016-2026)
10.3 South America Recombinant Hepatitis B Vaccine Market Size by Country
10.3.1 South America Recombinant Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Hepatitis B Vaccine Market Size by Country
11.3.1 Middle East & Africa Recombinant Hepatitis B Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Hepatitis B Vaccine Typical Distributors
12.3 Recombinant Hepatitis B Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Recombinant Hepatitis B Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Hepatitis B Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Recombinant Hepatitis B Vaccine Product and Services
Table 6. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Plc Major Business
Table 9. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product and Services
Table 10. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Inc. Major Business
Table 13. Pfizer Inc. Recombinant Hepatitis B Vaccine Product and Services
Table 14. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Pasteur Major Business
Table 17. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product and Services
Table 18. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 20. CSL Limited Major Business
Table 21. CSL Limited Recombinant Hepatitis B Vaccine Product and Services
Table 22. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 24. Emergent Biosolutions Major Business
Table 25. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product and Services
Table 26. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 28. Serum Institute of India Major Business
Table 29. Serum Institute of India Recombinant Hepatitis B Vaccine Product and Services
Table 30. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Major Business
Table 33. Johnson & Johnson Recombinant Hepatitis B Vaccine Product and Services
Table 34. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 36. Hualan Biological Engineering Major Business
Table 37. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product and Services
Table 38. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. NCPC Basic Information, Manufacturing Base and Competitors
Table 40. NCPC Major Business
Table 41. NCPC Recombinant Hepatitis B Vaccine Product and Services
Table 42. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 44. China National Biotec Group Major Business
Table 45. China National Biotec Group Recombinant Hepatitis B Vaccine Product and Services
Table 46. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Dalian Hissen Bio-pharm Basic Information, Manufacturing Base and Competitors
Table 48. Dalian Hissen Bio-pharm Major Business
Table 49. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product and Services
Table 50. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Beijing Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 52. Beijing Tiantan Biological Major Business
Table 53. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product and Services
Table 54. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Recombinant Hepatitis B Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Recombinant Hepatitis B Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Recombinant Hepatitis B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Recombinant Hepatitis B Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Recombinant Hepatitis B Vaccine Production Site of Key Manufacturer
Table 60. Recombinant Hepatitis B Vaccine New Entrant and Capacity Expansion Plans
Table 61. Recombinant Hepatitis B Vaccine Mergers & Acquisitions in the Past Five Years
Table 62. Global Recombinant Hepatitis B Vaccine Sales by Region (2016-2021e) & (K Units)
Table 63. Global Recombinant Hepatitis B Vaccine Sales by Region (2021-2026) & (K Units)
Table 64. Global Recombinant Hepatitis B Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Recombinant Hepatitis B Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Recombinant Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Units)
Table 67. Global Recombinant Hepatitis B Vaccine Sales by Type (2021-2026) & (K Units)
Table 68. Global Recombinant Hepatitis B Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Recombinant Hepatitis B Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Recombinant Hepatitis B Vaccine Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Recombinant Hepatitis B Vaccine Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Recombinant Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Units)
Table 73. Global Recombinant Hepatitis B Vaccine Sales by Application (2021-2026) & (K Units)
Table 74. Global Recombinant Hepatitis B Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Recombinant Hepatitis B Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Recombinant Hepatitis B Vaccine Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Recombinant Hepatitis B Vaccine Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Recombinant Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Units)
Table 79. North America Recombinant Hepatitis B Vaccine Sales by Country (2021-2026) & (K Units)
Table 80. North America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Recombinant Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Recombinant Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Units)
Table 83. North America Recombinant Hepatitis B Vaccine Sales by Type (2021-2026) & (K Units)
Table 84. North America Recombinant Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Units)
Table 85. North America Recombinant Hepatitis B Vaccine Sales by Application (2021-2026) & (K Units)
Table 86. Europe Recombinant Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Recombinant Hepatitis B Vaccine Sales by Country (2021-2026) & (K Units)
Table 88. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Recombinant Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Recombinant Hepatitis B Vaccine Sales by Type (2021-2026) & (K Units)
Table 92. Europe Recombinant Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Recombinant Hepatitis B Vaccine Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Recombinant Hepatitis B Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Recombinant Hepatitis B Vaccine Sales by Application (2021-2026) & (K Units)
Table 102. South America Recombinant Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Units)
Table 103. South America Recombinant Hepatitis B Vaccine Sales by Country (2021-2026) & (K Units)
Table 104. South America Recombinant Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Recombinant Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Recombinant Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Units)
Table 107. South America Recombinant Hepatitis B Vaccine Sales by Type (2021-2026) & (K Units)
Table 108. South America Recombinant Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Units)
Table 109. South America Recombinant Hepatitis B Vaccine Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Recombinant Hepatitis B Vaccine Typical Distributors
Table 121. Recombinant Hepatitis B Vaccine Typical Customers
List of Figures
Figure 1. Recombinant Hepatitis B Vaccine Picture
Figure 2. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2020
Figure 3. 10mcg/ml
Figure 4. 10mcg/0.5ml
Figure 5. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application in 2020
Figure 6. Newborn
Figure 7. Primary School Students
Figure 8. Adult
Figure 9. Global Recombinant Hepatitis B Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Recombinant Hepatitis B Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Recombinant Hepatitis B Vaccine Sales (2016-2026) & (K Units)
Figure 12. Global Recombinant Hepatitis B Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Recombinant Hepatitis B Vaccine Production Capacity (2016-2026) & (K Units)
Figure 14. Global Recombinant Hepatitis B Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Recombinant Hepatitis B Vaccine Market Drivers
Figure 16. Recombinant Hepatitis B Vaccine Market Restraints
Figure 17. Recombinant Hepatitis B Vaccine Market Trends
Figure 18. Global Recombinant Hepatitis B Vaccine Sales Market Share by Manufacturer in 2020
Figure 19. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Manufacturer in 2020
Figure 20. Recombinant Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Recombinant Hepatitis B Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Recombinant Hepatitis B Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2016-2026)
Figure 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2016-2026)
Figure 25. North America Recombinant Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 26. Europe Recombinant Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Recombinant Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. South America Recombinant Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue (2016-2026) & (USD Million)
Figure 30. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 31. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2016-2026)
Figure 32. Global Recombinant Hepatitis B Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 34. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2016-2026)
Figure 35. Global Recombinant Hepatitis B Vaccine Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 37. North America Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 38. North America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 39. North America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 40. United States Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 44. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 45. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 46. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 47. Germany Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Recombinant Hepatitis B Vaccine Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2016-2026)
Figure 56. China Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 63. South America Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 64. South America Recombinant Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 65. South America Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Recombinant Hepatitis B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …- 組換えハムスター卵巣細胞（CHO）B型肝炎ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chin…
- 世界の遺伝子組換え型タンパク質ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 肝炎治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis. Scope of the Report: This report studies the Hepatitis Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types…
- 世界の遺伝子組換え型ベクターワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Vector Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…